Title |
CD8+ T-Cell Responses in Acute Hepatitis C Virus Infection
|
---|---|
Published in |
Frontiers in immunology, June 2014
|
DOI | 10.3389/fimmu.2014.00266 |
Pubmed ID | |
Authors |
Pil Soo Sung, Vito Racanelli, Eui-Cheol Shin |
Abstract |
Hepatitis C virus (HCV) infects approximately 170 million people worldwide and is a major cause of life-threatening liver diseases such as liver cirrhosis and hepatocellular carcinoma. Acute HCV infection often progresses to chronic persistent infection, although some patients recover spontaneously. The divergent outcomes of acute HCV infection are known to be determined by differences in virus-specific T-cell responses among patients. Of the two major T-cell subsets, CD8(+) T-cells are known to be the key effector cells that control viral infections via cytolytic activity and cytokine secretion. Herein, we review various aspects of HCV-specific CD8(+) T-cell responses in acute HCV infection. In particular, we focus on timing of CD8(+) T-cell responses, relationship between CD8(+) T-cell responses and outcomes of acute HCV infection, receptor expression on CD8(+) T-cells, breadth of CD8(+) T-cell responses, and viral mutations. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 1 | 50% |
Switzerland | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Hungary | 1 | 2% |
India | 1 | 2% |
Russia | 1 | 2% |
Unknown | 52 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 22% |
Student > Bachelor | 10 | 18% |
Researcher | 7 | 13% |
Student > Master | 7 | 13% |
Student > Doctoral Student | 5 | 9% |
Other | 8 | 15% |
Unknown | 6 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 16 | 29% |
Medicine and Dentistry | 13 | 24% |
Agricultural and Biological Sciences | 9 | 16% |
Biochemistry, Genetics and Molecular Biology | 3 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 5 | 9% |
Unknown | 7 | 13% |